Pharmosa Biopharm Inc.
6875
Rank in Stocks
#19696
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Share Price
$0.77125681
Last synced: 2026-11-10
Market Cap
$99.63M
Change (1 day)
0.00%
Change (1 year)
-51.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pharmosa Biopharm Inc. (6875)
Category
Healthcare
EPS for Pharmosa Biopharm Inc. (6875)
EPS as of June 2026 TTM: $-0.08
According to Pharmosa Biopharm Inc.'s latest financial reports, its current EPS (TTM) is $-0.08. At the end of 2025 the company had an EPS of $-0.09, a decrease compared to its 2024 EPS of $-0.04.
EPS history for Pharmosa Biopharm Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.08 | -6.33% |
| 2025 | $-0.09 | 135.32% |
| 2024 | $-0.04 | -1,775.00% |
| 2023 | 0.00 | -102.78% |
| 2022 | $-0.09 | -18.57% |
| 2021 | $-0.11 | 53.55% |
| 2020 | $-0.07 | 60.32% |
| 2019 | $-0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -18,676.51% |
US
|
|
| $-7.07 | 8,286.71% |
US
|
|
| $-5.29 | 6,175.21% |
AU
|
|
| $12.88 | -15,378.88% |
BE
|
|
| $21.56 | -25,675.33% |
NL
|
Questions about Pharmosa Biopharm Inc.'s earnings per share (EPS)
What is Pharmosa Biopharm Inc.'s earnings per share (EPS)?
Pharmosa Biopharm Inc.'s earnings per share (EPS) over the last twelve months is $-0.08, as of Jun 2026.
What was Pharmosa Biopharm Inc.'s earnings per share (EPS) in 2025?
In 2025, Pharmosa Biopharm Inc.'s earnings per share (EPS) was $-0.09, compared with $-0.04 in 2024.
How has Pharmosa Biopharm Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Pharmosa Biopharm Inc.'s earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2021 ($-0.11).
How does Pharmosa Biopharm Inc.'s earnings per share (EPS) compare with similar companies?
Pharmosa Biopharm Inc.'s earnings per share (EPS) ($-0.08) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.